A Guide To Esophageal Cancer Clinical Trials
This actionable esophageal cancer guide lays out the considerations when managing your diagnosis to help you with the process and to make sure no step is missed along the way.
- The esophagus is a muscular tube that connects the throat to the stomach. The esophagus is eight inches long and lined with moist pink tissue (mucosa).
- Cancer of the esophagus starts when cells in the lining of the esophagus begin to grow out of control.
- Esophageal cancer is an aggressive disease that nearly 20,000 people will be diagnosed with in 2021 alone.
- Cancer of the esophagus is more common in men than in women. Many cases are linked to the use of tobacco, alcohol, or from excess body weight.
Trials Can Help
There are currently over 140 active esophageal cancer clinical trials taking place in the United States. Participating in a clinical trial not only progresses much-needed research, but also gives patients access to these new innovative therapies years before the general population.
The new treatments investigated in today’s esophageal cancer clinical trials are:
- Targeted therapies for new biomarkers
- Immunotherapy using new monoclonal antibodies
- Combinations of chemotherapies with other drugs
- New methods of surgery
At Massive Bio, our mission is to enable cancer patients to have equal access to cutting-edge therapies and clinical trials, regardless of their location and/or financial stability.
Our Artificial Intelligence (AI) powered Clinical Trial Matching System connects patients and their treating oncologists to clinical trials according to their unique cancer case.
We enlist dedicated staff to collect medical records and treatment history and match patients to eligible trials near their home. We provide full support throughout your enrollment process to ensure logistics are handled so you can concentrate on your health.